Document:

Amendment to Purchase and Separation Agreement

 Exhibit 10.2 
 EXECUTION COPY 
 FIRST AMENDMENT TO 
 PURCHASE AND SEPARATION AGREEMENT 
 This First Amendment, dated as of June 2, 2006
(this “Amendment”), to the Purchase and Separation Agreement (the “Agreement”), dated as of January 22, 2006, by and among Albertson's, Inc., a Delaware corporation (the “Company”), New Aloha
Corporation (n/k/a New Albertson's, Inc.), a Delaware corporation and wholly owned subsidiary of the Company (“New Diamond”), SUPERVALU INC., a Delaware corporation (“SV”), and AB Acquisition LLC, a Delaware limited
liability company (“Onyx”). 
 WHEREAS, the parties to the Agreement desire to enter into this Amendment to amend certain
provisions of the Agreement, as set forth below. 
 NOW, THEREFORE, in consideration of the premises and the mutual covenants and conditions
herein contained, the parties hereto hereby agree as follows: 
 Section 1. Capitalized Terms. All capitalized terms used in this
Amendment and not otherwise defined herein shall have their respective meanings set forth in the Agreement. 
 Section 2. Amendments.

 Section 2.1. Definitions. Section 1.1 of the Agreement is hereby amended by 
 (a) adding the following defined terms in alphabetical order: 
 “Capital Expenditure Adjustment” means an amount equal to (x) $18,557,000 minus (y) the amount actually expended in cash (and not financed with capital leases included in the Retained Liabilities) on
capital expenditures for, or directly in connection with, the Retained Business for the period from February 1, 2006 through June 1, 2006. 
 “Dispute Notice” has the meaning set forth in Section 6.15(c). 
 “Estimated
Capital Expenditure Adjustment” means $13,000,000. 
 “Estimated Retained Property Proceeds” means $29,000,000.

 “Headquarters Employee” shall mean any of the 14 employees listed on Schedule 2.1 that otherwise would be a New Diamond
Employee pursuant to clause (ii) of the definition of “New Diamond Employee” but that, within 90 days following the Closing Date, remains or becomes an employee of one of the Retained Entities. 
 “Headquarters Employee CIC Payment Reimbursement” has the meaning set forth in Section 6.15(a). 

 (b) deleting the definition of “New Diamond Assumption Price” in its entirety and inserting in
lieu thereof the following: 
 “New Diamond Assumption Price” means an amount of cash equal to (i) $620,000,000 in
respect of certain Liabilities to be assumed by New Diamond including Liabilities that, but for such assumption, would be Retained Liabilities minus (ii) the Option Adjustment Amount; 
 (c) adding at the end of the clause (v) of the definition of “New Diamond Liabilities” the following phrase: “American Drug Stores
Inc., American Partners, LP and Oakbrook Beverage Centers, Inc.”. 
 (d) deleting the definition of “Option Adjustment Amount”
and inserting in lieu thereof the following : 
 “Option Adjustment Amount” means $0. 
 (e) deleting the definition of “Retained Business Price” in its entirety and inserting in lieu thereof the following: 
 “Retained Business Price” means (i) $350,000,000 plus (ii) the New Diamond Assumption Price minus (iii) the
sum of (A) the Retained Property Proceeds and (B) the Capital Expenditure Adjustment; 
 Section 2.2. New Diamond Entities.
Schedule 1.5 to the Agreement is hereby amended by adding the following in alphabetical order to such schedule: 
 “American Drug Stores
Inc. 
 American Partners, LP 
 Oakbrook Beverage Centers, Inc.” 
 Section 2.3. Section 6.14 is hereby deleted in its entirety. 
 Section 2.4. SV Covenants. A new Section 6.15 shall be added to the Agreement, as follows: 
 “Section 6.15 CIC Payments. (a) SV shall pay to Onyx the Headquarters Employee CIC Reimbursement in accordance with
Section 6.15(b). The “Headquarters Employee CIC Payment Reimbursement” shall be an amount equal to the severance payments actually paid by Onyx or its Affiliate to Headquarters Employees pursuant to the Change in Control
Severance Agreements between the Company and such Headquarters Employees; provided, that the Headquarters Employee CIC Payment Reimbursement paid in respect of any Headquarters Employee shall not exceed the severance payments payable in
respect of such Headquarters Employee pursuant to the Change in Control Severance Agreement between the Company and such Headquarters Employee in effect as of immediately prior to the Effective Time. Notwithstanding the inclusion of any employee on
Schedule 2.1 as a Headquarters Employee, SV does not waive any of its rights with respect to such employee, and Onyx shall consult with SV prior to making any offer of employment to such employee. 
 (b) From time to time following the Closing Date, Onyx shall provide to SV a schedule identifying a Headquarters Employee whose employment by Onyx or its
subsidiaries 

  

 2 

 
has terminated and the amount of Headquarters Employee CIC Payment Reimbursement for such Headquarter Employee. SV shall pay to Onyx the amount of the
Payment Reimbursement, as finally determined pursuant to this Section 6.15, within 20 days of such final determination. All payments under this Section 6.15 shall be made by wire transfer of immediately available funds to an account or
accounts designated in writing by Onyx. Unless within 10 days after delivery of such schedule, SV shall deliver to Onyx a notice setting forth, in reasonable detail, any good faith dispute as to the Headquarters Employee CIC Payment
Reimbursement, specifying the items and amounts that are disputed and the basis for such dispute (a “Dispute Notice”), the amount of the Headquarters Employee CIC Payment Reimbursement set forth on Onyx's schedule shall be deemed
accepted by SV and shall be final and binding. For 10 days after Onyx's receipt of a Dispute Notice, the parties shall endeavor in good faith to resolve by mutual agreement all matters in the Dispute Notice. If the parties are unable to resolve any
matter in the Dispute Notice within such 10-day period, the parties shall arbitrate such matter in accordance with the provisions of Section 7.2 of the Transition Services Agreement.” 
 Section 2.5. Insurance Payments. A new Section 6.16 shall be added to the Agreement, as follows: 
 “Section 6.16. Insurance Payments. On or prior to the Closing Date, Onyx shall provide its consent to the assignment by the Company to New
Diamond of all property and casualty insurance policies issued to the Company or its Subsidiaries that are in effect on the Closing Date. Promptly following the Closing Date each of SV and Onyx shall (i) cooperate to recover, from their
insurers and insurance brokers, premiums attributable to the reduced coverage under such policies, and (ii) determine, based on the advice of their insurance brokers and consultants, the percentage of the premium reduction on such policies
attributable to the elimination, from and after the Closing Date, of the property and casualty risks relating to the Retained Assets and Retained Business (the “Insurance Adjustment Percentage”). SV shall pay, within 5 business days
of the determination thereof, Onyx an amount in cash equal to the product of (i) the Insurance Adjustment Percentage multiplied by (ii) the actual amount of premiums recovered from insurers and brokers as a result of such reduced coverage
(such product, the “Insurance Adjustment Amount”). If the parties are unable to reach agreement concerning the Insurance Adjustment Amount within 60 days following the Closing Date, then the parties shall arbitrate such matter in
accordance with the provisions of Section 7.2 of the Transition Services Agreement. 
 Section 2.6. Certain Properties.
Notwithstanding anything to the contrary contained in the Agreement or the schedules thereto, the parties hereto confirm that the real estate comprised of the Dublin and Scottsdale facilities more particularly described on Schedule 2.6 (the
“Facilities”) shall constitute Retained Assets, and that the real estate comprised of the Glendale facility shall constitute a New Diamond Asset. Onyx agrees that, for a period ending on the first anniversary of the Closing Date,
(i) New Diamond may continue to use on a rent-free basis (without any right of assignment or sublease) the portion of the Dublin Facility currently used by the Company, but subject to payment of its proportionate share of cleaning, routine
maintenance, utility and HVAC costs 

  

 3 

 
and property taxes, in a manner consistent with the past practice of the Company and its Subsidiaries, (ii) New Diamond may continue to use the entire
Scottsdale Facility on a rent-free basis (without any right of assignment or sublease), but subject to payment of its proportionate share of cleaning, routine maintenance, utility and HVAC costs and property taxes, and (iii) New Diamond may
allow CVS Corporation to use a portion of the Scottsdale Facility to be agreed upon between New Diamond and CVS Corporation on a rent-free basis, but subject to payment to Onyx of CVS Corporation's proportionate share of cleaning, routine
maintenance, utility and HVAC costs and property taxes. 
 Section 2.7. Certain Estimates and Adjustments. A new paragraph
(c) shall be added at the end of Section 2.8 of the Agreement, as follows: 
 “(c) The parties understand and agree that the
Retained Business Price paid by Onyx to New Diamond on the Closing Date will be calculated based on the Estimated Capital Expenditure Adjustment and the Estimated Retained Property Proceeds, which the parties agree are reasonable estimates of the
Capital Expenditure Adjustment and the Retained Property Proceeds. The parties will cooperate in good faith to determine the final value of the Capital Expenditure Adjustment and of the Retained Property Proceeds within thirty (30) days after
the Closing Date. The “Retained Business Price Adjustment” shall be an amount equal to the sum of (i) the difference between the Capital Expenditure Adjustment and the Estimated Capital Expenditure Adjustment and (ii) the
difference between the Retained Property Proceeds and the Estimated Retained Property Proceeds. Within thirty (30) days after the Closing Date, (A) if the Retained Business Price Adjustment is positive, New Diamond shall deliver to Onyx
the Retained Business Price Adjustment, and (B) if the Retained Business Price Adjustment is negative, Onyx shall deliver to New Diamond the Retained Business Price Adjustment. If the parties are unable to reach agreement concerning the
Retained Business Price Adjustment within 30 days following the Closing Date, then the parties shall arbitrate such matter in accordance with the provisions of Section 7.2 of the Transition Services Agreement.” 
 Section 2.8. Retained Properties and New Diamond Properties. 
 (a) Notwithstanding anything to the contrary in the Agreement, the schedules thereto or the Company Disclosure Letter delivered in connection therewith, the parties to the Agreement confirm and agree that (i) the
real property listed on Schedule 2.8.1 hereto shall constitute New Diamond Assets and (ii) the real property listed on Schedule 2.8.2 hereto shall constitute Retained Assets. With respect to any real property that as of the date hereof
(x) is owned or leased by the Company, New Diamond, the Retained Entities, or the New Diamond Entities and (y) is not listed on Schedule 2.8.1 or 2.8.2 hereto (an “Unscheduled Property”), the parties confirm their
agreement that, as provided in Section 4.15 of the Company Disclosure Letter delivered in connection with the Agreement, and except as expressly provided herein, from and after the date hereof, if and to the extent any such Unscheduled Property
is conclusively determined to qualify as a Retained Asset or a New Diamond Asset, as the case may be, by virtue of such property’s relationship to the Retained Business or the New Diamond Business, as applicable, then such determination shall
control whether such Unscheduled Property is deemed to be a Retained Asset or a New Diamond Asset, respectively, and, if applicable, the provisions of Section 6.1 (Further Assurances; Subsequent Transfers) of the Agreement shall control the
transfer of such property. 
 (b) Notwithstanding anything to the contrary contained in the Agreement, the schedules thereto or the Company
Disclosure Letter delivered in connection therewith, the parties understand and agree that any owned or leased real property identified by unit number as 

  

 4 

 
a Retained Asset or a New Diamond Asset, as the case may be, shall include any parcel of surplus real property associated with such unit of owned or leased
real property. 
 Section 2.9. Certain Standalone Drug Assets and Liabilities. 
 (a) Schedule 1.2 to the Agreement is hereby amended by amending paragraph 6 of that Schedule to read in its entirety as follows: 
 “6. any Asset of the Company or any of its Subsidiaries (including any surplus owned or leased real property) primarily related to their respective
retail drug store and pharmacy businesses in freestanding stores, to the extent that any such Asset is not a Purchased Asset under the Standalone Drug Sale Agreement, except as otherwise expressly provided in this Separation Agreement or the
schedules hereto.” 
 (b) Schedule 1.6 to the Agreement is hereby amended by amending paragraph 10 of that Schedule to read in its
entirety as follows: 
 “10. any Liability of the Company or any of its Subsidiaries (including any Liability related to any surplus
owned or leased real property) primarily related to their respective retail drug store and pharmacy businesses in freestanding stores, to the extent that any such Liability is not an Assumed Liability under the Standalone Drug Sale Agreement, except
as otherwise expressly provided in this Separation Agreement or the schedules hereto.” 
 Section 2.10. Certain Aircraft and
Satellite Assets. 
 (a) Paragraph 5 of Schedule 1.2 to the Agreement is hereby amended by adding the words, “if any”, after
the words “transportation equipment” in each place in that paragraph in which the words “transportation equipment” occur. 
 (b) A new paragraph (d) shall be added at the end of Section 2.8 of the Agreement, as follows: 
 “(d) New Diamond
shall pay to Onyx fifteen per cent (15%) of the saleable value (net of Taxes, any reasonable transaction costs and assumption of Liabilities) of the Pro Rata Assets (as defined in Schedule 1.2 hereto). Amounts payable in respect of any Pro Rata
Asset will be paid upon the earlier to occur of (i) the sale by New Diamond of such Pro Rata Asset and (ii) the one year anniversary of the Closing Date. If within 10 days after delivery of such payments, Onyx shall deliver to New
Diamond a notice setting forth, in reasonable detail, any good faith dispute as to the amount payable in respect of such Pro Rata Asset, specifying the items and amounts that are disputed and the basis for such dispute, the parties shall endeavor in
good faith to resolve by mutual agreement the amount payable in respect of such Pro Rata Asset. If the parties are unable to resolve the amount payable within a 10-day period, the parties shall arbitrate such matter in accordance with the provisions
of Section 7.2 of the Transition Services Agreement.” 
 Section 2.11. Six Sigma. For the avoidance of doubt, the parties
understand and agree that that certain Consulting Agreement between the Company and Six Sigma Academy International, L.L.C. (the “Six Sigma Contract”) is a service contract that requires 

  

 5 

 
bifurcation between the New Diamond Business and the Retained Business, as described on Schedules 1.2, 1.6, 1.7 and 1.10 to the Agreement, and that the
Retained Business’s share of obligations pursuant to the Six Sigma Contract are Retained Liabilities. 
 Section 3.
Miscellaneous. 
 Section 3.1. Governing Law. This Amendment shall be governed by and construed in accordance with the Laws of
the State of Delaware (without giving effect to choice of law principles thereof). 
 Section 3.2. Severability. If any term or other
provision of this Amendment is determined by a court of competent jurisdiction to be invalid, illegal or incapable of being enforced, all other terms and provisions of this Amendment shall nevertheless remain in full force and effect. Upon such
determination that any term or other provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith to modify this Amendment (and the Agreement, as necessary) so as to effect the original intent of the
parties as closely as possible in a mutually acceptable manner. 
 Section 3.3. Headings. The section and paragraph headings and table
of contents contained in this Amendment are for reference purposes only and shall not in any way affect the meaning or interpretation of this Amendment. 
 Section 3.4. Counterparts. This Amendment may be executed simultaneously in any number of counterparts, each of which shall be deemed an original but all of which together shall constitute one and the same
instrument. 
 Section 3.5. Full Force and Effect. Except as expressly amended hereby, the Agreement remains in full force and effect
in accordance with its terms. 
 Section 3.6. Entire Agreement. The Agreement (including the Schedules and Exhibits thereto and the
documents and instruments referred to therein, including the Merger Agreement and the Ancillary Agreements, including the Transition Services Agreement); the Management Agreement, dated as of June 2, 2006, by and between SV, New Diamond, Jewel
Food Stores, Inc., American Drug Stores, LLC, and Onyx; and this Amendment (including the exhibits hereto) constitutes the entire agreement and supersede all other prior agreements or understandings, written or oral, among the parties with respect
to the subject matter of the Agreement. 
 Section 3.7. Successors and Assigns; Binding Effect. This Amendment shall bind and inure to
the benefit of the parties hereto, and their respective successors and permitted assigns. 
 [Remainder of this page intentionally left
blank. Signature page follows.] 
  

 6 

 IN WITNESS WHEREOF, each party has caused this First Amendment to the Purchase and Separation Agreement
to be duly executed on its behalf by its duly authorized officer as of the date first written above. 
  

			
	ALBERTSON’S, INC.
		
	By:	 	/s/ William H. Arnold
		 	Name: William H. Arnold
		 	Title: Group Vice President
	
	 NEW ALBERTSON’S, INC.
 (f/k/a NEW ALOHA
CORPORATION)

		
	By:	 	/s/ William H. Arnold
		 	Name: William H. Arnold
		 	Title: Authorized Signator
	
	SUPERVALU INC.
		
	By:	 	/s/ J. Andrew Herring
		 	Name: J. Andrew Herring
		 	Title: Senior Vice President
	
	 AB ACQUISITION LLC

		
	By:	 	/s/ Lisa Gray
		 	Name: Lisa Gray
		 	Title: Vice President

  

 7Amendment to Asset Purchase Agreement

 Exhibit 10.4 
 EXECUTION COPY 
 AMENDMENT (this “Amendment”) dated as of June 2, 2006 to the Asset
Purchase Agreement dated as of January 22, 2006, among CVS Pharmacy, Inc., a Rhode Island corporation (“Buyer”), CVS Corporation, a Delaware corporation (“Parent”), Albertson’s, Inc., a Delaware
corporation (“Albertson’s”), New Aloha Corporation, a Delaware corporation (“New Diamond”), SUPERVALU INC., a Delaware corporation (“SUPERVALU”), and the entities listed on Annex A thereto
(such entities listed on Annex A together with Albertson’s, the “Sellers”) (the “Agreement”). Capitalized terms used but not defined herein shall have the meanings set forth in the Agreement. 
 WHEREAS, the parties hereto entered into the Agreement, pursuant to which Buyer agreed to purchase certain assets from the Sellers and to assume certain
related liabilities; 
 WHEREAS, the parties desire to amend the Agreement, as further set forth herein; and 
 WHEREAS, the parties have agreed to certain other amendments to the Agreement, including such amendments as set forth in the Employee Agreement (as
defined below) and certain other agreements including the Seasonal Products Agreement, the Prescription Drug Agreement, the Audit Agreement and the Import Orders Agreement (each as defined below). 
 NOW, THEREFORE, in consideration of the foregoing and the mutual covenants and agreements herein contained, and intending to be legally bound hereby, the
parties hereto agree as follows: 
 Section 1.01 . Merger. Section 1.01 of the Agreement shall be amended to add the words
“and subject to Section 1.07(d)” following the words “Except as otherwise provided below,” in the lead-in thereto. Section 1.02 of the Agreement shall be amended to add the words “and subject to
Section 1.07(d)” following the words “contained herein” in the lead-in thereto. Section 1.03 of the Agreement shall be amended to add the words “and subject to Section 1.07(d)” following the words
“conditions of this Agreement” in the lead-in thereto. Section 1.04 of the Agreement shall be amended to add the words “and subject to Section 1.07(d)” following the words “writing to the contrary” in the
lead-in thereto. Section 1.07 of the Agreement shall be amended by adding thereto a new subsection (d) to read: 
 (d)
Notwithstanding anything to the contrary contained herein, including in Sections 1.01, 1.02, 1.03 and 1.04, (i) the assets and liabilities that are allocated pursuant to Article 3 of the Texas Merger Agreement (as defined in Section 13.11)
to the surviving entities of the merger thereunder shall be transferred by operation of 

 
law only to such entities pursuant to such agreement, which shall be effective immediately prior to the Closing (ii) the assets allocated to ADSI-CVS,
LLC pursuant to Article 3 of the Texas Merger Agreement shall be Purchased Assets hereunder and the liabilities allocated to ADSI-CVS, LLC pursuant to Article 3 of the Texas Merger Agreement shall be Assumed Liabilities hereunder, including for
purposes of Section 11.02(b), (iii) the foregoing will not affect (i) the obligations of Albertsons to cause SV Successor, LLC to transfer assets in accordance with Section 1.01 hereunder or (ii) the obligation of Buyer to
assume liabilities in accordance with Section 1.03 (and the operation of Sections 1.02 and 1.04 shall also apply to such entity, if at all, no differently than to any other Subsidiary of Seller) and (iv) any liability of American Drug
Stores, Inc. to which ADSI-CVS, LLC may succeed by virtue of the merger under the Texas Merger Agreement that is inconsistent with the allocation of liabilities thereunder shall be an Excluded Liability hereunder, including for purposes of
Section 11.02(a). 
 Section 1.02 . Petty Cash and Other Adjustment. (a) Section 1.01(l) of the Agreement is hereby
amended and restated as follows: 
 (l) cash in cash registers at each Store as maintained in the ordinary course consistent with past
practice (“Petty Cash”); 
  

	 	(b)	The following Section 1.11 is hereby added to the Agreement: 

 Section 1.11. Petty Cash and Other Adjustment. As promptly as practicable after the Closing, the parties shall cooperate to determine the aggregate Petty Cash as of the Effective Time and, promptly after determination thereof,
if (i) the aggregate Petty Cash exceeds an amount equal to $2,000 multiplied by the aggregate number of Stores (the “Base Petty Cash”), then CVS shall pay to SUPERVALU such difference in immediately available funds, and
(ii) the aggregate Petty Cash is less than the Base Petty Cash, then SUPERVALU shall pay to CVS such difference in immediately available funds. Any payment pursuant to this Section 1.11 shall be treated for all purposes as an adjustment to
the Purchase Price. 
 Section 1.03 . Trailers and Tractors. (a) The text of 1.01(n) of the Agreement is hereby deleted and
replaced with the following : “all trailers and tractors included on Exhibit H hereto;”. 
  

 2 

 Section 1.04 . Non-Competition Agreements. The word “and” is hereby deleted at the end
of Section 1.01(o). The period is hereby replaced with “; and” at the end of Section 1.01(p) of the Agreement. The following section 1.01(q) is hereby added to the Agreement: 
 (q) to the extent assignable, all non-competition covenants or agreements relating solely to competition with any of the Stores in favor of any Seller
which were granted by a third-party transferor or seller of a Store in connection with the acquisition by any Seller of a Store. 
 Section
1.05 . The word “and” is hereby deleted at the end of Section 1.02(v). The period is hereby replaced with “; and” at the end of Section 1.02(w) of the Agreement. The following Section 1.02(x) is hereby added to the
Agreement: 
 (x) all trailers and tractors other than the trailers and tractors listed on Exhibit H attached hereto. 
 Section 1.06 . La Habra Inventory Adjustment. The text of Section 1.10 of the Agreement is hereby deleted and replaced with the following:

 Section 1.10. La Habra Inventory Adjustment. The Parties hereto acknowledge and agree that (i) the normal carrying value
of non-pharmaceutical inventory at the Distribution Center is eighty-two million five hundred thousand dollars ($82,500,000) (the “Normal Front Store Inventory Value”); and (ii) the normal carrying value of the pharmaceutical
inventory normally being held at the Distribution Center is forty-five million eight hundred thousand dollars ($45,800,000), in the case of this clause (ii) as further described in the Prescription Drug Agreement (the “Normal
Pharmaceutical Inventory Level”). 
 Within three days after the Closing, the parties will determine in good faith based on
Albertson’s cost method then in effect, the value of the non-pharmaceutical inventory (the “Actual Front Store Value”) and the value of the pharmaceutical inventory (the “Actual Pharmaceutical Value”) in each
case at the Distribution Center. 
 (a) As promptly as practicable after the Closing, CVS shall pay SUPERVALU in immediately available funds
according to the following parameters: 
 (i) if the Actual Front Store Value equals the Normal Front Store Inventory Value,
an amount equal to 30% of the Normal Front Store Inventory Value (the “Base Front Store Inventory Credit”); 
 (ii) if the Actual Front Store Value exceeds the Normal Front Store Inventory Value, an amount equal to the Base Front 

  

 3 

 
Store Inventory Credit plus the difference between the Actual Front Store Value and the Normal Front Store Inventory Value; or 
 (iii) if the Actual Front Store Value is less than the Normal Front Store Inventory Value, an amount equal to the Base Front Store
Inventory Credit minus the difference between the Normal Front Store Inventory Value and the Actual Front Store Value. 
 If the Actual
Front Store Value is equal to or less than the Normal Front Store Inventory Level minus the Base Front Store Inventory Credit, then SUPERVALU shall not be entitled to any payment under this Section 1.10(a). 
 (b) As promptly as practicable after the Closing, CVS shall pay SUPERVALU in immediately available funds according to the following parameters:

 (i) if the Actual Pharmaceutical Value equals the Normal Pharmaceutical Inventory Level, an amount equal to the sum of 30%
of the Branded Net Cost (as defined in the Prescription Drug Agreement) of the pharmaceutical inventory relating to branded pharmaceutical inventory, and 30% of the Generic Net Cost (as defined in the Prescription Drug Agreement) of the
pharmaceutical inventory relating to generic pharmaceutical inventory (the “Base Pharmaceutical Inventory Credit”); 
 (ii) if the Actual Pharmaceutical Value exceeds the Normal Pharmaceutical Inventory Level, an amount equal to the Base Pharmaceutical Inventory Credit plus an amount to be calculated pursuant to the Prescription Drug Agreement; or

 (iii) if the Actual Pharmaceutical Value is less than the Normal Pharmaceutical Inventory Level, an amount equal to the
Base Pharmaceutical Inventory Credit minus the difference between the Normal Pharmaceutical Inventory Level and the Actual Pharmaceutical Value. 
 If the Actual Pharmaceutical Value is equal to or less than the Normal Pharmaceutical Inventory Level minus the Base Pharmaceutical Inventory Credit, then SUPERVALU shall not be entitled to any payment under
this Section 1.10(b). 
 Any payment pursuant to this Section 1.10 shall be treated for all purposes as an adjustment to the
Purchase Price. 
  

 4 

 Section 1.07 . The following Section 7.05(c) is hereby added to the Agreement: 
 (c) Notwithstanding Section 1.02(i), Buyer and its Affiliates shall have a limited, non-transferable license to use the name “ADSI” in the
name of ADSI-CVS, LLC, which is one of the resulting entities in the Texas Merger Agreement, and “American Drug Stores” in the name of “American Drug Stores Delaware, L.L.C., the surviving entity in a merger with ADSI-CVS, LLC.

 Section 1.08 . The following is hereby added to the Agreement at the end of Section 8.02(c): 
 All Transfer Taxes incurred in connection with the merger of ADSI-ABS, LLC, with and into ADSI-CVS, LLC (the “CVS Texas Merger”) pursuant
to the Texas Merger Agreement shall be borne equally by Buyer on the one hand, and Sellers, on the other hand. All Transfer Taxes incurred as a result of the merger of American Drug Stores, Inc., an Illinois corporation, with and into ADSI-ABS, LLC,
a Texas limited liability company (the “Illinois-Texas Merger”), or as a result of the merger of ADSI-ABS, LLC with and into SV Successor LLC, a Texas limited liability company (the “SV Texas Merger”) pursuant to
the Texas Merger Agreement, shall be borne equally by Buyer on the one hand, and Sellers, on the other hand; provided, however, that the party responsible (the “Responsible Party”) under applicable law for reporting and/or
paying such Transfer Tax incurred as a result of the Illinois-Texas Merger or the SV Texas Merger shall be solely responsible for any interest and penalties attributable to the failure of such party to comply with applicable law with respect to such
Transfer Tax, unless (a) such failure is the result of actions or failures to act that have occurred with the prior written consent of the other party (the “Other Party”) or (b) the Other Party fails to provide its 50
percent share of the applicable Transfer Tax to the Responsible Party in advance of the due date under applicable law for the Transfer Tax but only if the Responsible Party has provided written demand therefor, along with reasonable supporting
documentation, to the Other Party within a reasonable period of time in advance of such date. For purposes of the immediately preceding sentence, Transfer Taxes shall be treated as incurred as a result of the Illinois-Texas Merger or the SV Texas
Merger only if and to the extent that (i) the aggregate amount of Transfer Taxes incurred as a result of the Illinois-Texas Merger and the SV Texas Merger (determined without regard to this sentence) exceeds (ii) the aggregate amount of
Transfer Taxes that would have been incurred as a result of a merger of American Drug Stores, Inc. into a Delaware limited liability company (the “Alternate Merger”) if 

  

 5 

 
the Alternate Merger had occurred prior to the sale of the Purchased Assets pursuant to the Agreement, such Delaware limited liability company had sold the
assets allocated to ADSI-CVS, LLC pursuant to Article 3 of the Texas Merger Agreement as contemplated by the Agreement prior to this Amendment and the other transactions contemplated by or occurring in connection with the Agreement or the Separation
Agreement had occurred, but the Illinois-Texas Merger, the SV Texas Merger and the CVS Texas Merger had not occurred (provided that such excess shall be reduced (without duplication), but not below zero, by the amount, if any, of Transfer Taxes
imposed on the Illinois-Texas Merger or the SV Texas Merger which result in an aggregate reduction in Transfer Tax imposed on one or more transactions contemplated by or occurring in connection with the Separation Agreement, other than any
transaction pursuant to the Agreement). 
 Section 1.09 . The following Section 8.03 is hereby added to the Agreement:

 Section 8.03. Treatment of Merger as Asset Transfer. The transfer of assets and liabilities to ADSI-CVS, LLC in the merger
effected pursuant to the Texas Merger Agreement shall be treated as a taxable sale and purchase of such assets (and assumption of such liabilities) occurring pursuant to this Agreement for all federal income tax purposes and, insofar as a state or
local income tax regime conforms to the federal income tax regime, for state and local income tax purposes. 
 Section 1.10 .
Indemnification. A new subsection 11.02(b)(iv) shall be added (and the “or” shall be moved from the end of clause (ii) to the end of clause (iii): that reads: 
 (iv) actions of North Dakota governmental agencies or North Dakota regulators arising from the Texas Merger Agreement or the transactions related thereto.

 Section 1.11 . Exhibits and Schedules. Exhibit A, Exhibit B, Exhibit C and Schedule 1.01(g) to the Agreement are hereby deleted and
replaced with the Exhibit A, Exhibit B, Exhibit C and Schedule 1.01(g) attached hereto. Exhibit H attached hereto is hereby added to the Agreement. 
 Section 1.12 . Other Agreements for Purposes of Entire Agreement Provision. The following is hereby inserted between “Agreement” and “and” on the first line of Section 13.11 of the Agreement: 
 the Employee Agreement dated as of June 2, 2006 (the “Employee Agreement”) between SUPERVALU Holdings Inc. and Parent; 

  

 6 

 
the Plan of Merger among ADSI-ABS, LLC, ADSI-CVS, LLC and SV Successor LLC (the “Texas Merger Agreement”); the Holiday and Seasonal Products
Agreement dated as of May 26, 2006 among Albertson’s, Parent and Buyer (the “Seasonal Products Agreement”); the Audit Process Agreement dated as of June 2, 2006 among Albertson’s Parent and Buyer (the
“Audit Agreement”); the Prescription Drug Inventory Agreement dated as of June 2, 2006 among Albertson’s, Parent and Buyer (the “Prescription Drug Agreement”) ; and the Import Orders Agreement dated as of
June 2, 2006 among Albertson’s, Parent and Buyer (the “Import Orders Agreement”). 
 Section 1.13 Governing
Law. This Amendment shall be governed by and construed in accordance with the law of the State of Delaware, without regard to the conflicts of law rules of such state. 
 Section 1.14 . Jurisdiction. Each of the parties hereto (i) consents to submit itself to the personal jurisdiction of the Court of Chancery
of the State of Delaware (and, with respect to claims in which the exclusive subject matter jurisdiction of such claims is federal, the federal district court for the District of Delaware) in the event any dispute arises out of this Amendment or any
of the transactions contemplated by this Amendment, (ii) agrees that it will not attempt to deny or defeat such personal jurisdiction by motion or other request for leave from such court, (iii) agrees that it will not bring any action
relating to this Amendment or any of the transactions contemplated by this Amendment in any court other than the Court of Chancery of the State of Delaware (or, with respect to claims in which the exclusive subject matter jurisdiction of such claims
is federal, the federal district court for the District of Delaware) and (iv) to the fullest extent permitted by Law, consents to service being made through the notice procedures set forth in Section 13.02 of the Agreement. Each party
hereto hereby agrees that, to the fullest extent permitted by Law, service of any process, summons, notice or document by U.S. registered mail to the respective addresses set forth in Section 13.02 of the Agreement shall be effective service of
process for any suit or proceeding in connection with this Amendment or the transactions contemplated hereby. 
 Section 1.15 . Effect of
Amendment. Except as amended hereby, the Agreement shall remain unchanged, and the Agreement as amended hereby shall be in full force and effect. 
 Section 1.16 . Counterparts. This Amendment may be signed in any number of counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same
instrument. The facsimile transmission of any signed original counterpart of this Amendment shall be deemed to be the delivery of an original counterpart of this Amendment. 
  

 7 

 IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed by their respective
authorized officers as of the day and year first above written. 
  

			
	CVS PHARMACY, INC.
		
	By:	 	/s/ Peter F. Pecoraio
		 	Name: Peter F. Pecoraio
		 	Title: Vice President
	
	CVS CORPORATION
		
	By:	 	/s/ ZENON P. LANKOWSKY
		 	Name: ZENON P. LANKOWSKY
		 	Title: SECRETARY & GENERAL COUNSEL
	
	ALBERTSONS LLC
		
	By:	 	/s/ SUSAN McMILLAN
		 	Name: SUSAN McMILLAN
		 	Title: AUTHORIZED SIGNATORY
	
	SUPERVALU INC.
		
	By:	 	/s/ J. Andrew Herring
		 	Name: J. Andrew Herring
		 	Title: Senior Vice President
	
	NEW ALBERTSON’S, INC.
		
	By:	 	/s/ SUSAN McMILLAN
		 	Name: SUSAN McMILLAN
		 	Title: AUTHORIZED SIGNATORY

  

 8 

			
	ABS FINANCE CO., INC.
		
	By:	 	/s/ SUSAN McMILLAN
		 	Name: SUSAN McMILLAN
		 	Title: AUTHORIZED SIGNATORY
	
	ABS PROCUREMENT CO.
		
	By:	 	/s/ SUSAN McMILLAN
		 	Name: SUSAN McMILLAN
		 	Title: AUTHORIZED SIGNATORY
	
	ACME MARKETS, INC.
		
	By:	 	/s/ SUSAN McMILLAN
		 	Name: SUSAN McMILLAN
		 	Title: AUTHORIZED SIGNATORY
	
	ADVANTAGE STORES, INC.
		
	By:	 	/s/ SUSAN McMILLAN
		 	Name: SUSAN McMILLAN
		 	Title: AUTHORIZED SIGNATORY
	
	ALBERTSONS ASSIST, INC.
		
	By:	 	/s/ SUSAN McMILLAN
		 	Name: SUSAN McMILLAN
		 	Title: AUTHORIZED SIGNATORY

  

 9 

			
	ALBERTSONS STORES CHARITABLE FOUNDATION, INC.
		
	By:	 	/s/ SUSAN McMILLAN
		 	Name: SUSAN McMILLAN
		 	Title: AUTHORIZED SIGNATORY
	
	SV SUCCESSOR LLC
		
	By:	 	/s/ SUSAN McMILLAN
		 	Name: SUSAN McMILLAN
		 	Title: AUTHORIZED SIGNATORY
	
	AMERICAN FOOD AND DRUG LLC
		
	By:	 	/s/ SUSAN McMILLAN
		 	Name: SUSAN McMILLAN
		 	Title: AUTHORIZED SIGNATORY
	
	AMERICAN PARTNERS, L.P.
	
	By: AMERICAN DRUG STORES, INC., its Managing General Partner
		
	By:	 	/s/ SUSAN McMILLAN
		 	Name: SUSAN McMILLAN
		 	Title: AUTHORIZED SIGNATORY

  

 10 

			
	AMERICAN PROCUREMENT AND LOGISTICS COMPANY LLC
		
	By:	 	/s/ SUSAN McMILLAN
		 	Name: SUSAN McMILLAN
		 	Title: AUTHORIZED SIGNATORY
	
	AMERICAN STORES CHARITABLE FOUNDATION
		
	By:	 	/s/ SUSAN McMILLAN
		 	Name: SUSAN McMILLAN
		 	Title: AUTHORIZED SIGNATORY
	
	AMERICAN STORES COMPANY, LLC
	
	By: ALBERTSON’S INC., its sole Member
		
	By:	 	/s/ SUSAN McMILLAN
		 	Name: SUSAN McMILLAN
		 	Title: AUTHORIZED SIGNATORY
	
	AMERICAN STORES PROPERTIES LLC
		
	By:	 	/s/ SUSAN McMILLAN
		 	Name: SUSAN McMILLAN
		 	Title: AUTHORIZED SIGNATORY

  

 11 

			
	AMERICAN STORES REALTY COMPANY, LLC
	
	By: AMERICAN STORES COMPANY, LLC, its sole Member
		
		 	By: ALBERTSON’s INC., its sole Member,
		
	By:	 	/s/ SUSAN McMILLAN
		 	Name: SUSAN McMILLAN
		 	Title: AUTHORIZED SIGNATORY
	
	APLC PROCUREMENT, INC.
		
	By:	 	/s/ SUSAN McMILLAN
		 	Name: SUSAN McMILLAN
		 	Title: AUTHORIZED SIGNATORY
	
	ASC MEDIA SERVICES, INC.
		
	By:	 	/s/ SUSAN McMILLAN
		 	Name: SUSAN McMILLAN
		 	Title: AUTHORIZED SIGNATORY
	
	BERYL AMERICAN CORPORATION
		
	By:	 	/s/ SUSAN McMILLAN
		 	Name: SUSAN McMILLAN
		 	Title: AUTHORIZED SIGNATORY

  

 12 

			
	HEALTH ‘n’ HOME LLC
		
	By:	 	/s/ SUSAN McMILLAN
		 	Name: SUSAN McMILLAN
		 	Title: AUTHORIZED SIGNATORY
	
	JETCO PROPERTIES, INC.
		
	By:	 	/s/ SUSAN McMILLAN
		 	Name: SUSAN McMILLAN
		 	Title: AUTHORIZED SIGNATORY
	
	JEWEL FOOD STORES, INC.
		
	By:	 	/s/ SUSAN McMILLAN
		 	Name: SUSAN McMILLAN
		 	Title: AUTHORIZED SIGNATORY
	
	JEWEL OSCO SOUTHWEST LLC
		
	By:	 	/s/ SUSAN McMILLAN
		 	Name: SUSAN McMILLAN
		 	Title: AUTHORIZED SIGNATORY
	
	KASCO AUTOMOTIVE PRODUCTS LLC
		
	By:	 	/s/ SUSAN McMILLAN
		 	Name: SUSAN McMILLAN
		 	Title: AUTHORIZED SIGNATORY

  

 13 

			
	LUCKY STORES PROPERTIES, INC.
		
	By:	 	/s/ SUSAN McMILLAN
		 	Name: SUSAN McMILLAN
		 	Title: AUTHORIZED SIGNATORY
	
	LUCKY STORES, INC. (DE)
		
	By:	 	/s/ SUSAN McMILLAN
		 	Name: SUSAN McMILLAN
		 	Title: AUTHORIZED SIGNATORY
	
	LUCKY STORES, INC. (FL)
		
	By:	 	/s/ SUSAN McMILLAN
		 	Name: SUSAN McMILLAN
		 	Title: AUTHORIZED SIGNATORY
	
	MFC-LIVONIA PROPERTIES, INC.
		
	By:	 	/s/ SUSAN McMILLAN
		 	Name: SUSAN McMILLAN
		 	Title: AUTHORIZED SIGNATORY
	
	OAKBROOK BEVERAGE CENTERS, INC.
		
	By:	 	/s/ SUSAN McMILLAN
		 	Name: SUSAN McMILLAN
		 	Title: AUTHORIZED SIGNATORY

  

 14 

			
	OSCO DRUG OF MASSACHUSETTS LLC
		
	By:	 	/s/ SUSAN McMILLAN
		 	Name: SUSAN McMILLAN
		 	Title: AUTHORIZED SIGNATORY
	
	OSCO DRUG OF TEXAS LLC
		
	By:	 	/s/ SUSAN McMILLAN
		 	Name: SUSAN McMILLAN
		 	Title: AUTHORIZED SIGNATORY
	
	SAV-ON REALTY LLC
		
	By:	 	/s/ SUSAN McMILLAN
		 	Name: SUSAN McMILLAN
		 	Title: AUTHORIZED SIGNATORY
	
	SCOLARI’S STORES LLC
		
	By:	 	/s/ SUSAN McMILLAN
		 	Name: SUSAN McMILLAN
		 	Title: AUTHORIZED SIGNATORY
	
	SUNRICH MERCANTILE LLC
		
	By:	 	/s/ SUSAN McMILLAN
		 	Name: SUSAN McMILLAN
		 	Title: AUTHORIZED SIGNATORY

  

 15 

			
	U.S. SATELLITE CORPORATION
		
	By:	 	/s/ SUSAN McMILLAN
		 	Name: SUSAN McMILLAN
		 	Title: AUTHORIZED SIGNATORY

  

 16

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00105-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00105-of-00352.parquet"}]]